Lisa Ricciardi, president and CEO of Cognition Therapeutics was recently a guest on Benzinga's All-Access. Cognition ...

The third most common form of dementia is often mistaken for Alzheimer's despite different treatment needsCognitive profiles ...

All 16 of Indiana’s designated senior care organizations are now required to have a dementia outreach specialist. The goal is ...

D imaging and organoid models are revolutionizing dementia research, offering deeper insights into disease mechanisms and ...

While many people take supplements for brain health, the research supporting supplemental nutrients' effects on brain health ...

The world’s largest study of proteins circulating the human body will begin in the UK this month, with the aim of pinpointing ...

A world leading UK Biobank study of half a million Brits could unlock the mysteries of ‘proteomics’ to prevent and cure ...

Researchers believe a simple blood test could flag people who are in the early stages of Alzheimer's, as well as spotting ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

Alzheimer’s drugs could unlock a $13 billion market by 2030, with Biogen, Eli Lilly, Novo Nordisk, Roche, and UCB leading the ...

The nonprofit announced Thursday that 1,119 organs were transplanted last year and 1,960 people donated tissue in 2024 — ...

Researchers have discovered that suppressing a nucleolar complex can reduce Alzheimer’s-related protein toxicity. Scientists ...